Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Enstilar

    - PMLiVE

    LEO Pharma receives NICE approval for chronic hand eczema cream

    The cream can now be prescribed for patients when topical corticosteroids have not worked or are not suitable

    - PMLiVE

    J&J’s Tremfya approved by FDA for children with plaque psoriasis and psoriatic arthritis

    The drug is the first IL-23 inhibitor approved for children from the age of six

    - PMLiVE

    Global Healthy Living Foundation and Medscape Education Join Forces to Bridge the Gap Between Patients and Providers with Immunology Education

    UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...

    Medscape Education

    - PMLiVE

    Almirall and Absci expand AI dermatological drug discovery partnership

    The alliance has already led to the delivery of functional antibody leads against a difficult-to-drug target

    - PMLiVE

    Apogee Therapeutics’ atopic dermatitis candidate shows promise in phase 2 study

    The inflammatory skin condition affects over 26 million people in the US

    - PMLiVE

    LEO’s Anzupgo granted FDA approval to treat moderate-to-severe chronic hand eczema

    The cream is now the first treatment approved by the regulator specifically for this patient population

    - PMLiVE

    Honoring the Legacy of Dr. Robert Sidbury, MD, MPH

    We are deeply saddened by the recent passing of Dr. Robert Sidbury. Dr. Sidbury was a visionary in pediatric dermatology whose dedication to advancing patient care inspired clinicians, researchers, and...

    Medscape Education

    - PMLiVE

    LEO Pharma gains access to Boehringer’s skin disease drug for €90m upfront

    Spevigo is already approved in over 40 countries to treat generalised pustular psoriasis

    - PMLiVE

    FDA approves new presentation of Celltrion’s SteQeyma for paediatric psoriasis

    The Stelara biosimilar now offers all dosage forms and strengths of its reference product

    - PMLiVE

    Dermaliq and DEBRA partner to advance epidermolysis bullosa drug delivery

    Approximately 500,000 people worldwide are affected by the rare genetic skin disorders

    - PMLiVE

    LEO Pharma and the Parker Institute join forces to advance dermatology research

    The alliance will aim to discover molecules that could be incorporated into wider pharmaceutical research

    - PMLiVE

    LEO and Reig Jofre partner to improve access to psoriasis therapy in Europe

    Approximately 125 million people worldwide are affected by some form of the inflammatory condition

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links